294 related articles for article (PubMed ID: 11384100)
1. Frequent p53 mutation in brain (fetal)-type glycogen phosphorylase positive foci adjacent to human 'de novo' colorectal carcinomas.
Shimada S; Shiomori K; Tashima S; Tsuruta J; Ogawa M
Br J Cancer; 2001 Jun; 84(11):1497-504. PubMed ID: 11384100
[TBL] [Abstract][Full Text] [Related]
2. Genetic pathways of 'de novo' colorectal carcinomas with reference to fetal-type glycogen phosphorylase positive foci.
Shiomori K; Shimada S; Marutsuka T; Hatayama I; Ogawa M
Int J Oncol; 2003 Jan; 22(1):65-74. PubMed ID: 12469186
[TBL] [Abstract][Full Text] [Related]
3. Carcinogenesis of intestinal-type gastric cancer and colorectal cancer is commonly accompanied by expression of brain (fetal)-type glycogen phosphorylase.
Shimada S; Tashima S; Yamaguchi K; Matsuzaki H; Ogawa M
J Exp Clin Cancer Res; 1999 Mar; 18(1):111-8. PubMed ID: 10374690
[TBL] [Abstract][Full Text] [Related]
4. Expression of brain-type glycogen phosphorylase is a potentially novel early biomarker in the carcinogenesis of human colorectal carcinomas.
Tashima S; Shimada S; Yamaguchi K; Tsuruta J; Ogawa M
Am J Gastroenterol; 2000 Jan; 95(1):255-63. PubMed ID: 10638593
[TBL] [Abstract][Full Text] [Related]
5. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.
Kusaka T; Fukui H; Sano Y; Ueda Y; Chiba T; Fujimori T
J Gastroenterol Hepatol; 2000 Oct; 15(10):1151-7. PubMed ID: 11106095
[TBL] [Abstract][Full Text] [Related]
6. K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer.
Notarnicola M; Cavallini A; Cardone R; Pezzolla F; Demma I; Di Leo A
Dig Liver Dis; 2000 Mar; 32(2):131-6. PubMed ID: 10975788
[TBL] [Abstract][Full Text] [Related]
7. K-ras and p53 mutations in colonic lavage fluid of patients with colorectal neoplasias.
Heinzlmann M; Neynaber S; Heldwein W; Folwaczny C
Digestion; 2001; 63(4):229-33. PubMed ID: 11435722
[TBL] [Abstract][Full Text] [Related]
8. APC and p53 mutations in de novo colorectal adenocarcinomas.
Aoki T; Takeda S; Yanagisawa A; Kato Y; Ajioka Y; Watanabe H; Kudo S; Nakamura Y
Hum Mutat; 1994; 3(4):342-6. PubMed ID: 8081386
[TBL] [Abstract][Full Text] [Related]
9. APC, K-ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gall-bladder carcinogenesis.
Itoi T; Watanabe H; Ajioka Y; Oohashi Y; Takel K; Nishikura K; Nakamura Y; Horil A; Saito T
Pathol Int; 1996 May; 46(5):333-40. PubMed ID: 8809879
[TBL] [Abstract][Full Text] [Related]
10. Frequent p53 gene mutations in serrated adenomas of the colorectum.
Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
[TBL] [Abstract][Full Text] [Related]
11. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
[TBL] [Abstract][Full Text] [Related]
12. A frequent alteration of p53 gene in carcinoma in adenoma of colon.
Ohue M; Tomita N; Monden T; Fujita M; Fukunaga M; Takami K; Yana I; Ohnishi T; Enomoto T; Inoue M
Cancer Res; 1994 Sep; 54(17):4798-804. PubMed ID: 8062281
[TBL] [Abstract][Full Text] [Related]
13. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon.
Yamashita N; Minamoto T; Ochiai A; Onda M; Esumi H
Gastroenterology; 1995 Feb; 108(2):434-40. PubMed ID: 7835585
[TBL] [Abstract][Full Text] [Related]
14. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
[TBL] [Abstract][Full Text] [Related]
15. Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.
Einspahr JG; Martinez ME; Jiang R; Hsu CH; Rashid A; Bhattacharrya AK; Ahnen DJ; Jacobs ET; Houlihan PS; Webb CR; Alberts DS; Hamilton SR
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1443-50. PubMed ID: 16896030
[TBL] [Abstract][Full Text] [Related]
16. [Mutations of APC and K-ras gene in aberrant crypt foci from human colon].
Yuan P; Sun M; Zhang J; Zhu X; Shi D
Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):35-8. PubMed ID: 11866955
[TBL] [Abstract][Full Text] [Related]
17. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
18. Histological and genetic changes in malignant transformation of gallbladder adenoma.
Watanabe H; Date K; Itoi T; Matsubayashi H; Yokoyama N; Yamano M; Ajioka Y; Nishikura K
Ann Oncol; 1999; 10 Suppl 4():136-9. PubMed ID: 10436806
[TBL] [Abstract][Full Text] [Related]
19. Polyamine biosynthesis in relation to K-ras and p-53 mutations in colorectal carcinoma.
Linsalata M; Notarnicola M; Caruso MG; Di Leo A; Guerra V; Russo F
Scand J Gastroenterol; 2004 May; 39(5):470-7. PubMed ID: 15180186
[TBL] [Abstract][Full Text] [Related]
20. Novel subtyping of intestinal metaplasia in the human stomach: brain-type glycogen phosphorylase expression in the proliferative zone and its relationship with carcinogenesis.
Matsuzaki H; Shimada S; Uno K; Tsuruta J; Ogawa M
Am J Clin Pathol; 1998 Feb; 109(2):181-9. PubMed ID: 9583890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
